MDMA Archives | Cannabiz

‘This is just the beginning’: BLS CEO on German expansion and vision for firm

by Adam Sheldon August 6, 2026August 6, 2026

A shortage of flower meeting Germany’s post-harvest GMP requirements is constraining the growth of BLS Pharmaceuticals, […]

News in brief: BLS inks US psychedelic referral deal

by Adam Sheldon July 22, 2026July 22, 2026

News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules

by Adam Sheldon November 11, 2025February 21, 2026

Vitura JV Cortexa starts local manufacture of MDMA

by Martin Lane April 5, 2024July 16, 2024

Emyria inks deal to study MDMA-assisted therapy for first responders

by Martin Lane April 3, 2024July 16, 2024

Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue

by Steve Jones February 7, 2024February 7, 2024

Vitura JV to take delivery of first batch of psychedelic medicines

by cannabiz team July 26, 2023April 30, 2024

Emyria shares take a hit as company raises another A$2.5 million

by Steve Jones May 1, 2023April 30, 2024

Emyria and LGP shares soar after TGA approves limited access to MDMA and psilocybin

by Steve Jones February 6, 2023April 29, 2024

Emyria posts A$7m loss but insists 2023 will be ‘momentous’

by Steve Jones August 30, 2022April 29, 2024